These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 10366993)
1. Pharmacokinetics and hypotensive effect of diltiazem in rabbits after a single intravenous administration: effect of phenobarbital. Yeung PK; Feng JD; Buckley SJ Drug Metabol Drug Interact; 1998; 14(3):179-92. PubMed ID: 10366993 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and hypotensive effect of deacetyl N-monodesmethyl diltiazem (M2) in rabbits after a single intravenous administration. Yeung PK; Feng JD; Buckley SJ Eur J Drug Metab Pharmacokinet; 1998; 23(1):27-31. PubMed ID: 9625269 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and haemodynamic effect of deacetyl diltiazem (M1) in rabbits after a single intravenous administration. Yeung PK; Feng JD; Buckley SJ Biopharm Drug Dispos; 1998 Mar; 19(2):109-13. PubMed ID: 9533111 [TBL] [Abstract][Full Text] [Related]
4. Penetration of diltiazem into breast milk and its pharmacokinetics in the lactating rabbit. Rueda S; Fraile LJ; Bregante MA; Garcia MA; Solans C Xenobiotica; 2002 Feb; 32(2):119-30. PubMed ID: 11868968 [TBL] [Abstract][Full Text] [Related]
5. Effect of phenobarbital pretreatment on the pharmacokinetics and metabolism of diltiazem in rats. Yeung PK; Buckley SJ; Cameron R; Feng JD; Jordan J Drug Metabol Drug Interact; 1996; 13(1):29-39. PubMed ID: 8902429 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and hypotensive effect of diltiazem in rabbits: comparison of diltiazem with its major metabolites. Yeung PK; Feng JD; Buckley SJ J Pharm Pharmacol; 1998 Nov; 50(11):1247-53. PubMed ID: 9877310 [TBL] [Abstract][Full Text] [Related]
7. Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation. Jones DR; Gorski JC; Hamman MA; Mayhew BS; Rider S; Hall SD J Pharmacol Exp Ther; 1999 Sep; 290(3):1116-25. PubMed ID: 10454485 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and hemodynamic effects of diltiazem in healthy volunteers: comparing resting with the effect of exercise. Yeung PK; Hung OR; Pollak PT; Klassen GA Int J Clin Pharmacol Ther; 1999 Aug; 37(8):413-6. PubMed ID: 10475144 [TBL] [Abstract][Full Text] [Related]
9. Studies on interactions between functional foods or dietary supplements and medicines. I. Effects of Ginkgo biloba leaf extract on the pharmacokinetics of diltiazem in rats. Ohnishi N; Kusuhara M; Yoshioka M; Kuroda K; Soga A; Nishikawa F; Koishi T; Nakagawa M; Hori S; Matsumoto T; Yamashita M; Ohta S; Takara K; Yokoyama T Biol Pharm Bull; 2003 Sep; 26(9):1315-20. PubMed ID: 12951478 [TBL] [Abstract][Full Text] [Related]
10. Identification of the rabbit and human cytochromes P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem. Pichard L; Gillet G; Fabre I; Dalet-Beluche I; Bonfils C; Thenot JP; Maurel P Drug Metab Dispos; 1990; 18(5):711-9. PubMed ID: 1981725 [TBL] [Abstract][Full Text] [Related]
11. Deacetylation of diltiazem by several rabbit tissues. Fraile LJ; Aramayona JJ; Bregante MA; García MA; Abadía AR Pharm Res; 1996 Dec; 13(12):1875-80. PubMed ID: 8987088 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and metabolism of diltiazem in rabbits after a single intravenous or single oral administration. Yeung PK; Mosher SJ; Pollak PT Eur J Drug Metab Pharmacokinet; 1991; 16(1):69-74. PubMed ID: 1936064 [TBL] [Abstract][Full Text] [Related]
13. Metabolite-intermediate complexation and inhibition of microsomal CYP3A in rat liver by diltiazem. Trieu L; Murray M Xenobiotica; 2000 Feb; 30(2):131-40. PubMed ID: 10718121 [TBL] [Abstract][Full Text] [Related]
14. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites. Sutton D; Butler AM; Nadin L; Murray M J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567 [TBL] [Abstract][Full Text] [Related]
15. Intravenous diltiazem and CYP3A-mediated metabolism. Masica AL; Azie NE; Brater DC; Hall SD; Jones DR Br J Clin Pharmacol; 2000 Sep; 50(3):273-6. PubMed ID: 10971313 [TBL] [Abstract][Full Text] [Related]
16. Effect of administration route and length of exposure on pharmacokinetics and metabolism of diltiazem in dogs. Yeung PK; Feng JD; Buckley SJ Drug Metabol Drug Interact; 2001; 18(3-4):251-62. PubMed ID: 11791888 [TBL] [Abstract][Full Text] [Related]
17. Diltiazem blood pharmacokinetics in the pregnant and non-pregnant rabbit: maternal and foetal tissue levels. Bregante MA; Aramayona JJ; Fraile LJ; Garcia MA; Solans C Xenobiotica; 2000 Aug; 30(8):831-41. PubMed ID: 11037114 [TBL] [Abstract][Full Text] [Related]
18. The effect of multiple doses of ranitidine on the pharmacokinetics and metabolism of diltiazem in dogs. Yeung PK; Mosher SJ; Landriault H Biopharm Drug Dispos; 1994 Apr; 15(3):207-15. PubMed ID: 7880981 [TBL] [Abstract][Full Text] [Related]
19. Exercise hemodynamic and neurohormone responses as sensitive biomarkers for diltiazem in rats. Yeung PK; Feng JD; Fice D J Pharm Pharm Sci; 2006; 9(2):245-51. PubMed ID: 16959194 [TBL] [Abstract][Full Text] [Related]
20. Effect of diltiazem on hemodynamics and regional blood flows in the newborn piglet. Clozel M; Hascoet JM; Clozel JP; Monin P; Vert P Dev Pharmacol Ther; 1986; 9(1):32-43. PubMed ID: 3948637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]